Advertisement

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Agenda 650x100px
All >

Deals > Austria

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria or involving Austrian organisations.

Total search results: 190 | Ordered by Date (descending)
1 2  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Cyprumed–MC Services: public relations, 202504 service existent MC Services is media contact 2025-04-15
Merck (US)–Cyprumed: drug delivery technology, 202504– license + option agreem for oral drug delivery of peptide therapeutics 2025-04-15
Xund Solutions–J&T Ventures (CZ): investment, 202503 financing round pre-Series A totalling €6m incl new + co-investor J&T Ventures 2025-03-05
Xund Solutions–Lana Ventures: investment, 202503 financing round pre-Series A totalling €6m incl existing + co-investor Lana Ventures 2025-03-05
Xund Solutions–Lead Ventures (HU): investment, 202503 financing round pre-Series A totalling €6m incl new + lead investor Lead Ventures 2025-03-05
Xund Solutions–MassMutual: investment, 202503 financing round pre-Series A totalling €6m incl existing + co-investor MassMutual Ventures 2025-03-05
Xund Solutions–SEVERAL: investment, 202503 financing round pre-Series A €6m led by Lead Ventures 2025-03-05
Xund Solutions–Tyrolean Business Angel Network: investment, 202503 financing round pre-Series A totalling €6m incl existing + co-investor tba network 2025-03-05
Graph Therapeutics–SEVERAL: investment, 202501 pre-seed financing round $3.1m led by Squareone + Merantix Capital 2025-01-09
Invios–MC Services: public relations, 202410 service existent by MC Services 2024-11-13
Mediaire–G8Way Ventures: investment, 202411 financing round totalling €12m incl existing + co-investor Gateway Ventures 2024-11-12
UpNano–Austria (govt): investment, 202410 financing round Series A totalling €7m incl co-lead investor aws Gründungsfonds 2024-10-17
UpNano–IGO Industries: investment, 202410 financing round Series A totalling €7m incl existing + co-lead investor IGO Innovation GmbH 2024-10-17
UpNano–ILUM Tec: investment, 202410 financing round Series A totalling €7m incl existing + co-investor ILUM Tec 2024-10-17
UpNano–Merloni: investment, 202410 financing round Series A totalling €7m incl co-lead investor NovaCapital 2024-10-17
UpNano–SEVERAL: investment, 202410 financing round Series A €7m co-led by aws Gründungsfonds + NovaCapital + IGO Innovation 2024-10-17
Invios–SEVERAL: investment, 202410 financing round Series A €8.2m incl existing investors + Ligand Pharmaceuticals 2024-10-15
a:head bio–SEVERAL: investment, 202410 financing round pre-Series A 7-digit EUR from existing + new investors 2024-10-09
Clock Bio–Onsight Ventures: investment, 202410 seed financing round totalling $5.3m incl co-investor Onsight Ventures 2024-10-09
Aitiologic–Austria (govt): grant, 202306–202410 grants from aws + FFG 2024-10-01
Aitiologic–Lana Ventures: investment, 202306–202410 seed financing round incl co-lead investor LANA Ventures 2024-10-01
Aitiologic–Push Ventures: investment, 202306–202410 seed financing round incl co-lead investor PUSH VC 2024-10-01
Aitiologic–SEVERAL: investment, 202306–202410 seed financing round >€2.5m (incl aws + FFG grants) led by Push VC + Lana Ventures 2024-10-01
Erbe Elektromedizin–1BillionLives: quality management software, 202409 supply existent Erbe is customer of Flinn.ai 2024-09-30
Austrian Academy of Sciences–Boehringer: grant, 202409–203608 funding €150m establishment + operation of AITHYRA Institute over 12y by BIS 2024-09-18
Bespark Bio–Austria (govt): grant, 202409 FFG grant €381.5k 2024-09-16
Aitiologic–Siemens: liquid biopsy technology, 202409c license excl to IP related to aitios platform initially developed by founder at S Healthineers 2024-09-01
1BillionLives–Cherry Ventures: investment, 202408 seed financing round totalling €6m incl lead investor Cherry Ventures 2024-08-03
1BillionLives–OTHER: investment, 202408 seed financing round totalling €6m incl business angels incl M Weber + M Reitermann 2024-08-03
1BillionLives–SEVERAL: investment, 202408 seed financing round €6m of Flinn led by Cherry Ventures 2024-08-03
1BillionLives–Speedinvest: investment, 202408 seed financing round totalling €6m incl existing + co-investor Speedinvest 2024-08-03
1BillionLives–SquareOne: investment, 202408 seed financing round totalling €6m incl existing + co-investor SquareOne VC 2024-08-03
Apeiron–Ligand: investment, 202407 acquisition $100m plus milestones + up to $28m royalties of Apeiron Biologics by Ligand Pharmaceuticals SIGNED 2024-07-08
Invios–Ligand: investment, 202407 investment up to €4m in InviosHolding AG by Ligand 2024-07-08
Venga Ventures–SEVERAL: investment, 202407– fund raising with max target size of €40m to €50m 2024-07-08
Ygion Biomedical–OTHER: investment, 202405 financing round Series A €15m from Austrian private trust (maybe AVV Investment??) 2024-05-21
Single Use Support–Novo Group: investment, 202405 acquisition of 60% majority share by Novo Holdings 2024-05-15
Boehringer–CBmed: cancer drugs, 202402– collab long-term strategic alliance €na using translational medicine to develop personalised cancer treatments 2024-02-08
Zetta Genomics–Apex Ventures: investment, 202402 2nd seed financing round expansion totalling £1.8m incl existing investor Apex Ventures 2024-02-08
ABS Biotechnologies–OBN: investor conference, 202401 supply service ABS Biotechnologies presents at BioSeed 2024 London 2024-01-22
Olgram–OBN: investor conference, 202401 supply service Olgram presents at BioSeed 2024 London 2024-01-22
Evomedis–MC Services: public relations, 202311 service existent by MC Services 2023-11-23
Valanx Biotech–Niederösterreich (govt): investment, 202311 growth financing totalling €2.3m equity + public funding incl existing investor TE 2023-11-07
Valanx Biotech–SEVERAL: investment, 202311 growth financing round €2.3m incl equity + public funding led by SkyGene 2023-11-07
Valanx Biotech–SkyGene: investment, 202311 growth financing round totalling €2.3m in equity + public funding incl new + lead investor SkyGene 2023-11-07
Valanx Biotech–SOSV: investment, 202311 growth financing totalling €2.3m equity + public funding incl existing investor SOSV 2023-11-07
Valanx Biotech–Xista Science Ventures: investment, 202311 growth financing round totalling €2.3m equity + public funding incl existing investor Xista 2023-11-07
HeartBeat.bio–MC Services: public relations, 202311 service existent by MC Services 2023-11-02
HeartBeat.bio–SEVERAL: investment, 202311 financing round pre-Series A €4.5m with i&i Biotech Fund + Invest AG + aws + Tensor Ventures 2023-11-02
CMBlu Energy–STRABAG: investment, 202310 equity investment €100m in connection with preferred partnership agreement 2023-10-23
STRABAG––CMBlu Energy: energy storage solutions, 202310– strategic collab preferred supplier agreement for SolidFlow batteries 2023-10-23
Biotech Austria–MC Services: public relations, 202310 service existent by MC Services 2023-10-17
Kern Tec–EU (govt): investment, 202309 financing round Series A totalling €12m incl co-investor EIC Fund 2023-09-27
Kern Tec–PeakBridge: investment, 202309 financing round Series A totalling €12m incl co-investor PeakBridge Growth 2 fund 2023-09-27
Kern Tec–SEVERAL: investment, 202309 financing round Series A €12m led by Telos Impact (eventually total includes grants?) 2023-09-27
Kern Tec–Telos Impact: investment, 202309 financing round Series A totalling €12m incl lead investor Telos Impact 2023-09-27
1BillionLives–Austria (govt): grant, 202307–202606 3y grant €2m from FFG for Flinn 2023-07-01
Nyra Health–SEVERAL: investment, 202306 seed financing round €4.5m co-led by MassMutual Ventures + Wellington Partners 2023-06-16
Michor Consulting–QbD Group: investment, 202305 acquisition of Michor Consulting by QbD Group 2023-05-25
Brutkasten–VGN Medien: investment, 202305 acquisition of majority share by VGN Medien Holding as strategic investor 2023-05-17
Zetta Genomics–Apex Ventures: investment, 202304 2nd seed financing round totalling £1.9m incl existing + co-investor Apex Ventures 2023-04-18
Merck (US)–Proxygen: molecular glue degraders, 202304– strategic multi-year collab + license agreem upfront payment + €2.55b milestones plus royalties 2023-04-05
Proxygen–Vida Strategic Partners: public relations, 202304 service existent by Vida Strategic Partners 2023-04-05
Refined Laser Systems–Apex Ventures: investment, 202301 seed financing round totalling €2.7m incl co-lead investor Apex Medical Fund 2023-01-26
Refined Laser Systems–Onsight Ventures: investment, 202301 seed financing round totalling €2.7m incl co-investor Onsight Ventures 2023-01-26
1BillionLives–Paua Ventures: investment, 202212 pre-seed financing round of Flinn totalling €1.8m incl co-lead investor Paua Ventures 2022-12-01
1BillionLives–SEVERAL: investment, 202212 pre-seed financing round €1.8m of Flinn led by Speedinvest + Paua Ventures 2022-12-01
1BillionLives–Speedinvest: investment, 202212 pre-seed financing round totalling €1.8m of Flinn incl co-lead investor Speedinvest 2022-12-01
Sarcura–Axilium Holding: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Axilium Holding 2022-11-17
Sarcura–HCVC: investment, 202211 seed plus financing round totalling €7m incl new + co-investor HCVC 2022-11-17
Sarcura–IST Cube: investment, 202211 seed plus financing round totalling €7m incl existing + co-lead investor IST Cube 2022-11-17
Sarcura–Lansdowne Partners: investment, 202211 seed plus financing round totalling €7m incl existing + co-lead investor Lansdowne Investment Co Cyprus 2022-11-17
Sarcura–Merloni: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor NovaCapital 2022-11-17
Sarcura–Niederösterreich (govt): investment, 202211 seed plus financing round totalling €7m incl new + co-investor Tecnet Equity 2022-11-17
Sarcura–Nina Capital: investment, 202211 seed plus financing round totalling €7m incl existing + co-investor Nina Capital 2022-11-17
Sarcura–OTHER: investment, 202211 seed plus financing round totalling €7m incl European family offices as new investors 2022-11-17
Sarcura–SEVERAL: investment, 202211 seed plus financing round €7m co-led by Lansdowne Investment Co Cyprus + IST Cube 2022-11-17
Celeris Therapeutics–EU (govt): grant, 202210 EIC Accelerator grant €2.5m 2022-10-19
Celeris Therapeutics–EU (govt): investment, 202210 equity investment up to €10m from EIC Accelerator 2022-10-19
Xund Solutions–Lana Ventures: investment, 202209 seed financing round totalling €6m incl co-investor Lana Ventures 2022-09-29
Xund Solutions–MassMutual: investment, 202209 seed financing round totalling €6m incl co-lead investor MassMutual Ventures 2022-09-29
Xund Solutions–MMC Ventures: investment, 202209 seed financing round totalling €6m incl co-lead investor MMC Ventures 2022-09-29
Xund Solutions–Roche: investment, 202209 seed financing round totalling €6m incl co-investor RoX Health 2022-09-29
Xund Solutions–SEVERAL: investment, 202209 seed financing round €6m co-led by MMC Ventures + MassMutual Ventures 2022-09-29
BioDGraft–NLC Ventures: investment, 202209 existent seed investor NLC 2022-09-27
Boehringer–Quantro Therapeutics: cancer drugs, 202208–202507 collab + option + license agreem €na r+d small-molecule transcription factor inhibitors 2022-08-03
Biosynth Carbosynth–Eucodis Bioscience: industrial enzymes, 202208 collab existent for many years 2022-08-02
Eucodis Bioscience–Biosynth Carbosynth: investment, 202208 acquisition of Eucodis by Biosynth Carbosynth 2022-08-02
UpNano–IGO Industries: investment, 202207 capital increase with existing investors incl IGO Industries 2022-07-05
UpNano–SEVERAL: investment, 202207 capital increase with existing investors incl IGO Industries 2022-07-05
Kranus Health–Peak Pride: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Peak Pride 2022-06-20
Merck (DE)–Proxygen: molecular glue degraders, 202206– strategic multi-year collab + license agreem up to €495m plus royalties 2022-06-02
Boehringer–Celeris Therapeutics: protein degradation drugs, 202204– collab AI-based drug discovery for target of Boehringer 2022-04-04
Innovacell–EU (govt): credit, 202203– venture debt loan of up to €15m from EIB to Innovacell AG 2022-03-24
Merck (DE)–Celeris Therapeutics: AI-based drug discovery, 202202– collab research small molecule binders + bifunctional degraders 2022-03-09
Marinomed–MC Services: public relations, 202202 service existent by MC Services 2022-02-15
Celeris Therapeutics–Apex Ventures: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor Apex Ventures 2022-02-10
Celeris Therapeutics–i&i Biotech Fund: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor i&i Biotech Fund 2022-02-10
Celeris Therapeutics–Longevitytech.fund: investment, 202202 seed financing round totalling $4.4m incl existing + co-investor Longevitytech.fund 2022-02-10
Celeris Therapeutics–Pace Ventures Enigma: investment, 202202 seed financing round totalling $4.4m incl new + co-lead investor Pace Ventures Enigma 2022-02-10
1 2  next pagenext page



Advertisement

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x300px

» top